Alvotech SEC filings ALVO
Alvotech has 302 filings in SEC EDGAR's recent list, going back to Dec 20, 2021. Its latest annual report, Form 20-F, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 20, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Aug 7, 2025 | — |
| CORRESP | Letter to the SEC | Jul 31, 2025 | — |
| UPLOAD | Letter from the SEC | Jul 21, 2025 | — |
| EFFECT | Filing | Aug 29, 2024 | — |
| CORRESP | Letter to the SEC | Aug 27, 2024 | — |
| UPLOAD | Letter from the SEC | Aug 23, 2024 | — |
| RW | Filing | Jun 26, 2024 | — |
| EFFECT | Filing | Oct 30, 2023 | — |
| CORRESP | Letter to the SEC | Oct 27, 2023 | — |
| UPLOAD | Letter from the SEC | Oct 26, 2023 | — |
| EFFECT | Filing | Jul 21, 2023 | — |
| EFFECT | Filing | Jul 20, 2023 | — |
| CORRESP | Letter to the SEC | Jul 20, 2023 | — |
| UPLOAD | Letter from the SEC | Jul 20, 2023 | — |
| EFFECT | Filing | Mar 16, 2023 | — |
| EFFECT | Filing | Sep 21, 2022 | — |
| EFFECT | Filing | Sep 21, 2022 | — |
| CORRESP | Letter to the SEC | Sep 19, 2022 | — |
| CORRESP | Letter to the SEC | Sep 19, 2022 | — |
| CORRESP | Letter to the SEC | Jul 27, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 27, 2022 | — |
| UPLOAD | Letter from the SEC | Jul 22, 2022 | — |
| CERT | Filing | Jun 16, 2022 | — |
| 8-A12B | Filing | Jun 13, 2022 | — |
| 425 | Filing | Jun 9, 2022 | — |
| 425 | Filing | Jun 7, 2022 | — |
| 425 | Filing | Jun 3, 2022 | — |
| 425 | Filing | May 31, 2022 | — |
| 425 | Filing | May 24, 2022 | — |
| 425 | Filing | May 17, 2022 | — |
| SEC STAFF LETTER | Filing | May 16, 2022 | — |
| 425 | Filing | May 16, 2022 | — |
| 425 | Filing | May 11, 2022 | — |
| EFFECT | Filing | May 10, 2022 | — |
| CORRESP | Letter to the SEC | May 10, 2022 | — |
| CORRESP | Letter to the SEC | May 10, 2022 | — |
| UPLOAD | Letter from the SEC | May 9, 2022 | — |
| CORRESP | Letter to the SEC | May 2, 2022 | — |
| CORRESP | Letter to the SEC | May 2, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 28, 2022 | — |
| 425 | Filing | Apr 22, 2022 | — |
| 425 | Filing | Apr 19, 2022 | — |
| CORRESP | Letter to the SEC | Apr 19, 2022 | — |
| 425 | Filing | Apr 18, 2022 | — |
| UPLOAD | Letter from the SEC | Apr 12, 2022 | — |
| 425 | Filing | Apr 6, 2022 | — |
| CORRESP | Letter to the SEC | Apr 4, 2022 | — |
| UPLOAD | Letter from the SEC | Mar 30, 2022 | — |
| 425 | Filing | Mar 23, 2022 | — |
| 425 | Filing | Mar 23, 2022 | — |
| CORRESP | Letter to the SEC | Mar 14, 2022 | — |
| 425 | Filing | Mar 8, 2022 | — |
| 425 | Filing | Feb 28, 2022 | — |
| UPLOAD | Letter from the SEC | Feb 25, 2022 | — |
| 425 | Filing | Feb 23, 2022 | — |
| 425 | Filing | Feb 15, 2022 | — |
| CORRESP | Letter to the SEC | Feb 4, 2022 | — |
| 425 | Filing | Feb 2, 2022 | — |
| SEC STAFF LETTER | Filing | Jan 21, 2022 | — |
| 425 | Filing | Jan 18, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 18, 2022 | — |
| 425 | Filing | Jan 10, 2022 | — |
Showing 62 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ALVO (Nasdaq), ALVOW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Luxembourg
- Headquarters
- Luxembourg, Luxembourg
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1898416
- Former names
- Alvotech Lux Holdings S.A.S. (until May 2, 2022)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.